NASDAQ$AXON

Axon Enterprise Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Axon's Q2 2021 performance was strong, with significant revenue growth and increased international presence.

Axon Enterprise reported a strong Q2 2021, with revenue up 55% year-over-year to $219 million. International revenue grew 60%, and the company raised its full-year outlook. The company's performance was driven by increasing global demand for its life-saving technology, including TASER devices and body cameras.

  • Revenue of $219 million grew 55% year over year.
  • International revenue grew 60% year over year and international bookings nearly tripled versus Q2 2020.
  • Annual Recurring Revenue (ARR) grew 42% year over year to $260 million.
  • Total company future contracted revenue surpassed $2 billion.

Headline financials

Total Revenue

$219M

Previous: $141M+54.9%
EPS (adj)

$0.38

Previous: -$0.01+3900.0%
Capital Expenditures

-$24M

Previous: -$7.55M-218.2%
Free Cash Flow

-$71.1M

Previous: -$38.3M-85.7%
Net Income

-$47.1M

Previous: -$30.8M-53.2%
Operating Income

-$93.7M

Previous: -$13.7M-585.0%
Gross Profit

$138M

Previous: $88.2M+56.4%
Cash & Equivalents

$266M

Previous: $319M-16.6%
Total Assets

$1.53B

Previous: $1.23B+23.8%
Stock-Based Comp

$138M

Previous: $33.8M+306.5%

Revenue & EPS history

Axon · Revenue · Quarterly

$219M

Q2 2021+54.9%vs Q2 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Axon · $113M total across 1 segment · Q2 2021

  • TASER
    $113M+59.6%

Forward guidance

Axon expects to achieve revenue in the range of $825 million to $850 million and Adjusted EBITDA to a range of $155 million to $160 million for 2021.

Tailwinds

  • Revenue in the range of $825 million to $850 million is expected.
  • Adjusted EBITDA is expected to be in the range of $155 million to $160 million.
  • The company intends to continue investing for growth.
  • The company's investments are yielding results ahead of expectations.
  • The business in 2022 includes approximately $960 million in revenue.

Headwinds

  • Stock-based compensation expense is expected to be more than $275 million for the full year.
  • Forecasting stock-based compensation expense is inherently difficult.
  • Expectations for capital expenditures of approximately $65 million to $70 million in 2021 are unchanged.
  • Forward-looking statements are subject to risks and uncertainties.
  • The company is exposed to cancellations of government contracts due to appropriation clauses.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+3.4%

Avg return

Earnings day

+6.6%

Avg return

5 days after

+6.7%

Avg return

30 days after

55%

35 / 64 earnings

Positive

+31.3%

Q3 2024

Best reaction

-17.1%

Q4 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%+3.1%+27.9%
Q4 2025+1.1%+29.3%-2.8%
Q3 2025+13.7%-17.2%-22.0%
Q1 2025+14.2%+20.4%+31.6%
Q4 2024+15.3%+5.9%+7.7%
Q3 2024+31.3%+29.5%+49.7%
Q2 2024+22.0%+27.6%+24.0%
Q1 2024-1.8%-4.7%-11.4%
Q4 2023+13.9%+15.7%+15.2%
Q3 2023+5.9%+0.5%+8.5%
Q2 2023+11.6%+17.6%+20.3%
Q1 2023-13.1%-9.2%-12.2%
Q4 2022+13.4%+13.3%+11.7%
Q3 2022+15.8%+23.2%+15.7%
Q2 2022+8.5%+11.4%+5.6%
Q1 2022-4.0%+11.8%+15.0%
Q4 2021+9.6%+16.1%+8.4%
Q3 2021+4.3%+6.8%-13.4%
Q2 2021+0.8%-3.8%-3.3%
Q1 2021-4.6%-6.6%-0.1%
Q4 2020+2.5%+2.9%-14.6%
Q3 2020+16.7%+13.3%+18.2%
Q2 2020-9.5%-14.5%-10.8%
Q1 2020+30.2%+26.2%+40.3%
Q4 2019-3.8%-2.9%-7.5%
Q3 2019+25.0%+22.5%+37.6%
Q2 2019-11.4%-10.3%-5.4%
Q1 2019-4.9%-1.0%+3.3%
Q4 2018-4.4%-6.2%-7.2%
Q3 2018-16.1%-13.6%-26.4%
Q2 2018-10.6%-8.1%+5.1%
Q1 2018+21.6%+27.4%+41.4%
Q4 2017+23.7%+37.6%+39.6%
Q3 2017-7.7%-8.9%+4.8%
Q2 2017-10.5%-13.1%-16.4%
Q1 2017+4.8%+3.8%-2.4%
Q4 2016-6.7%-12.5%-11.0%
Q3 2016+19.3%+22.3%+6.0%
Q2 2016+1.9%-0.1%-7.5%
Q1 2016+2.9%
Q4 2015+11.2%
Q3 2015-13.8%
Q2 2015-14.1%
Q1 2015+15.3%
Q4 2014-13.2%
Q3 2014+14.4%
Q2 2014+4.9%
Q1 2014-10.7%
Q4 2013+7.3%
Q3 2013+13.5%
Q2 2013-0.2%
Q1 2013+7.8%
Q4 2012-17.1%
Q3 2012-1.7%
Q2 2012-1.1%
Q1 2012+0.0%
Q4 2011-0.5%
Q3 2010-2.7%
Q3 2011-2.7%
Q2 2010-2.7%
Q2 2011-2.7%
Q1 2011+4.8%
Q4 2010-4.8%
Q1 2010+6.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro